Advertisement
![Picture [iito] No Tracking 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-tracking.jpg)
Document › Details
Merck KGaA. (7/23/21). "Press Release: Merck Announces Appointment of Head of China & International for Healthcare. Hong Chow Will Join the Healthcare Business Sector as Head of China & International on October 1". Darmstadt.
![]() |
Region | China |
![]() |
Organisation | Merck KGaA |
Group | Merck (DE) (Group) | |
Organisation 2 | Roche Pharma (Group Division) | |
Group | Roche (Group) | |
![]() |
Product | pharmaceutical |
Product 2 | healthcare | |
![]() |
Person | Chow, Hong (Merck (DE) 202110– Head of China + International for Healthcare before Roche + Bayer/Schering) |
Person 2 | Guenter, Peter (Merck (DE) 202101– CEO Healthcare before Almirall + Sanofi + SmithKline + Ciba-Geigy) | |
Hong Chow will join the Healthcare business sector as Head of China & International on October 1.
Merck, a leading science and technology company, today announced that Hong Chow will join its Healthcare business sector as Head of China & International on October 1. In this role at Merck, Chow will lead China, Japan as well the regions Europe, Latin America, Asia-Pacific and Middle East, Africa and Russia, the franchise of Cardiovascular Metabolism & Endocrinology (CM&E), and the Global Business Innovation team. Chow will report to Peter Guenter, Member of the Executive Board of Merck and CEO Healthcare. She will serve as a member of the Healthcare Executive Committee, and be based in Shanghai, China.
“Hong’s international experience and strong track record of bringing innovative medicines to patients in need across both developed and emerging markets, most notably China, will help drive our company’s strategic priorities,” said Guenter. “I look forward to Hong joining our team and contributing to both our purpose for patients and our Healthcare performance.”
Chow holds German citizenship and is currently CEO of Roche Pharmaceuticals in China. She is also a member of the Supervisory Board at Beiersdorf AG. Prior to joining Roche, Chow held various leadership roles at Bayer Healthcare across China, Asia-Pacific and Europe. She holds a degree in Business Administration from both Berlin School of Economics and Law and Anglia Ruskin University, Cambridge, United Kingdom.
“I am inspired by Merck’s 353-year legacy of scientific exploration, entrepreneurship, and long-term commitment towards human progress,” said Chow. “I look forward to joining Merck and together with the team delivering essential medicines that make a difference to millions of patients every day.”
For more information, please contact Andreas Cezanne
+49 151 1454 2702
All Merck Press Releases are distributed by e-mail at the same time they become available on the Merck Website. Please go to http://www.merckgroup.com/subscribe to register online, change your selection or discontinue this service.
About Merck
Merck, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck generated sales of € 17.5 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics.
Record changed: 2022-02-05 |
Advertisement
![Picture [iito] No Content Marketing 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-no-content-marketing.jpg)
More documents for Merck (DE) (Group)
- [1] Tolremo Therapeutics AG. (6/22/22). "Press Release: Tolremo Therapeutics AG Announces Appointment of Dr. Karl Schumacher as Chief Medical Officer". Muttenz....
- [2] Proxygen GmbH. (6/2/22). "Press Release: Proxygen Announces Strategic Collaboration with Merck to Develop Molecular Glue Degraders". Vienna....
- [3] Merck KGaA. (4/29/22). "Press Release: Merck Invests Approximately € 100 Million to Accelerate Single-Use Manufacturing in China". Darmstadt....
- [4] Merck KGaA. (4/5/22). "Press Release: Merck Advances BioProcessing Capabilities with Acquisition of MAST Platform from Lonza, a Leading Automated Bioreactor Sampling System". Darmstadt....
- [5] Celeris Therapeutics GmbH. (2/9/22). "Press Release: CelerisTx in Artificial Intelligence Research Collaboration with Merck KGaA, Darmstadt, Germany on AI-enabled Degrader Discovery". Menlo Park, CA....
- [6] Merck KGaA. (2/7/22). "Press Release: Merck Announces Organizational Transformation of Life Science Business Sector to Strengthen CDMO Offering and Accelerate Future Growth". Darmstadt....
- [7] eTheRNA Immunotherapeutics N.V.. (2/3/22). "Press Release: eTheRNA Announces Research Agreement with Merck to Access mRNA technologies". Niel....
- [8] Merck KGaA. (1/13/22). "Press Release: Merck Announces New Appointments in Global R&D and Strategy Leadership for Healthcare Business Sector". Darmstadt....
- [9] Merck KGaA. (1/6/22). "Press Release: Definitive Agreement to Acquire Exelead will Strengthen Merck’s CDMO Offering for mRNA". Darmstadt....
- [10] Merck KGaA. (12/20/21). "Press Release: Merck Expands Neuroinflammatory Pipeline with Acquisition of Chord Therapeutics [ Not intended for UK and US based media ]". Darmstadt....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
» top